Bandingkan Harga & Kinerja Kabelindo Murni Tbk (KBLM) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kabelindo Murni Tbk dan Organon Pharma Indonesia Tbk.: Kabelindo Murni Tbk diperdagangkan di Rp352 (kapitalisasi pasar 394,24 M, volume 24 jam 540,5 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Kabelindo Murni Tbk jauh lebih besar — sekitar 3,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KBLM | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 394,24 M | 104,4 M |
Volume | 540,5 rb | — |
Lot | 5,41 rb | — |
Perputaran | 189,11 jt | — |
Harga Rata-rata | 349,88 | — |
Nilai Transaksi | 189,11 jt | — |
Harga Ekuilibrium Indikatif | 352 | — |
Volume Ekuilibrium Indikatif | 11 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kabelindo Murni Tbk
PT Kabelindo Murni Tbk (the Company) was established based on Notarial Deed No. 71 dated October 11, 1979 of Fredrik Alexander Tumbuan, S.H. PT Kabelindo Murni Tbk manufactures cable and cable fittings using raw materials such as polyethylene and heat shrinkable materials tubes. Installed production capacity has reached 26,000 tons of power cables and 1,330,000 Km pair of telephone cables.
Selengkapnya di halaman KBLM →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
